Collegium Pharmaceutical Inc Net Asset Quality Index
Collegium Pharmaceutical Inc net asset quality index. Collegium Pharmaceutical Inc (COLL) has a Net Asset Quality Index of 17.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.61 Billion minus total liabilities of $1.33 Billion yields net assets of $274.81 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check COLL operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Collegium Pharmaceutical Inc (2013–2024)
Net asset quality index of Collegium Pharmaceutical Inc from 2013 to 2024. This chart shows how Collegium Pharmaceutical Inc's Net Asset Quality Index has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the index stands at 17.1%, representing net assets of $274.81 Million against total assets of $1.61 Billion USD. See shareholders equity of Collegium Pharmaceutical Inc for net asset value and shareholders' equity analysis.
Collegium Pharmaceutical Inc Net Asset Quality Index by Year (2013–2024)
Collegium Pharmaceutical Inc net asset quality index by year from 2013 to 2024. The table below presents the year-by-year Net Asset Quality Index for Collegium Pharmaceutical Inc from 2013 to 2024, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Collegium Pharmaceutical Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 13.8% | $228.84 Million | $1.66 Billion | $1.43 Billion | ▼ -3.3 pp |
| 2023 | 17.1% | $195.43 Million | $1.14 Billion | $947.88 Million | ▲ +0.5 pp |
| 2022 | 16.6% | $194.84 Million | $1.17 Billion | $979.29 Million | ▼ -12.7 pp |
| 2021 | 29.3% | $202.93 Million | $692.08 Million | $489.15 Million | ▲ +0.4 pp |
| 2020 | 28.9% | $186.03 Million | $643.84 Million | $457.81 Million | ▲ +0.3 pp |
| 2019 | 28.5% | $87.43 Million | $306.30 Million | $218.87 Million | ▼ -2.9 pp |
| 2018 | 31.4% | $91.58 Million | $291.25 Million | $199.66 Million | ▼ -45.3 pp |
| 2017 | 76.8% | $104.08 Million | $135.57 Million | $31.49 Million | ▼ -6.5 pp |
| 2016 | 83.3% | $134.91 Million | $162.02 Million | $27.11 Million | ▼ -3.8 pp |
| 2015 | 87.1% | $85.07 Million | $97.72 Million | $12.65 Million | ▲ +327.5 pp |
| 2014 | -240.5% | $-12.24 Million | $5.09 Million | $17.33 Million | ▼ -302.3 pp |
| 2013 | 61.8% | $5.58 Million | $9.03 Million | $3.45 Million | — |